Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma. - Wikidata - awgldk - TriplyDB

Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma.

Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma.

http://www.wikidata.org/entity/Q40345265

about

Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase theta facilitates induction of CYP17 PPARs and the cardiovascular system Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b Molecular recognition of nitrated fatty acids by PPARγ New members of the mammalian glycerophosphodiester phosphodiesterase family: GDE4 and GDE7 produce lysophosphatidic acid by lysophospholipase D activity Identifying plausible adverse drug reactions using knowledge extracted from the literature Lysophosphatidic acid activates peroxisome proliferator activated receptor-γ in CHO cells that over-express glycerol 3-phosphate acyltransferase-1 Aiming drug discovery at lysophosphatidic acid targets.Endogenous ligands for nuclear receptors: digging deeper.Lysophosphatidic acid increases the electrophysiological instability of adult rabbit ventricular myocardium by augmenting L-type calcium current PTB-associated splicing factor (PSF) is a PPARγ-binding protein and growth regulator of colon cancer cells.Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer.Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid.The early- and late stages in phenotypic modulation of vascular smooth muscle cells: differential roles for lysophosphatidic acid Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity PPAR γ Networks in Cell Signaling: Update and Impact of Cyclic Phosphatidic Acid.Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine.Lysophospholipid interactions with protein targets.Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.Peroxisomes: a nexus for lipid metabolism and cellular signaling.Release of cyclic phosphatidic acid from gelatin-based hydrogels inhibit colon cancer cell growth and migration.Structural and functional roles of ether lipids.Lysophospholipid signaling: beyond the EDGs.Sphingosine 1-phosphate pKa and binding constants: intramolecular and intermolecular influences.LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line.Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs.The PTB-Associated Splicing Factor/Peroxisome Proliferator-Activated Receptor Gamma Axis Regulates Autophagosome Formation in Human Pancreatic Cancer Cells.Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis.Alpha-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists.Heart-type fatty-acid-binding protein (FABP3) is a lysophosphatidic acid-binding protein in human coronary artery endothelial cells.PexRAP Inhibits PRDM16-Mediated Thermogenic Gene Expression.The novel ZIP4 regulation and its role in ovarian cancer.Lysophospholipid-Related Diseases and PPARγ Signaling Pathway.Inhibition of the Mitochondrial Pyruvate Carrier by Tolylfluanid.Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ.

P2860

Q24323350-E64E8281-190E-4DC7-A658-EAAB83BEA768 Q24642728-7BE62FA6-254A-449F-A97C-6DC0A1FDEE23 Q25257883-7964C7B7-47DC-4484-AE10-5A1612CBD581 Q27651047-6FB8F451-9E3A-4B33-915E-D8A7E87E0378 Q28509679-066F2F61-DE05-4F3E-8DE8-DA88CBE85159 Q28650098-5E1EDF76-F143-4F24-9776-0BDA07915F66 Q28740882-38EA136F-DDA3-406E-88F9-72DFF9C179E1 Q34339759-29786EEE-C8D3-4BD7-8851-5B3A8CD159DD Q34412495-57AA47AE-928C-4F4E-B090-0155BD9A2DF3 Q34430249-203E6C55-5B0A-46DF-86F6-6878D6909108 Q34629987-FB84AE4F-9D72-4CB3-BFF4-E2A47EE98534 Q35101709-74A8754F-F047-4FDB-869A-A69A97CFE2B6 Q36246883-77DB2B83-1C70-40B2-A00F-927871E78CB7 Q36246905-793FD5DC-EB1B-4A20-84B7-9159150D9509 Q36306320-18716DB3-45DA-4336-9DAA-197F8C01B8F2 Q36637912-DDDA1485-B6A9-4273-BDD7-26B323A295BB Q36772839-E6D7D575-A58B-43C9-A6A4-9D5D0D9DEEA8 Q36930850-9A27393B-0642-466C-BDB9-36968F9BBB6C Q37384489-A89C2277-F9E1-4D0B-8659-E64EFC919D23 Q37633445-AE96EE18-3EDB-48A4-9FAE-0879915659A7 Q39272192-EF0DBBE8-50B5-4A44-BFE9-6C7D1073B889 Q39317295-C2C00C70-1D7A-4C8F-8CA6-F77593E2EE20 Q40068942-049F0F44-1BB2-499E-B8F4-F472B3B3C5E3 Q40139534-9CAF2CA8-35F1-4033-80B6-652CD4C44FA5 Q40195489-9CD6572D-D7AD-41DB-94CA-C4B162E225E5 Q40210629-8ED5B5A0-BAC4-41D1-89AC-CFBEC2F9AEEA Q40604936-EB2E057B-F5C5-436C-A24F-C085BE4C9FE4 Q40927773-F5768E70-86D0-4A1C-AD28-BE6533288F6D Q41954435-B88449BC-78E3-4376-B40F-990050FB8E59 Q42148203-0FCDE012-A158-4649-9678-E59C3C7E38DE Q42185295-EF8F3465-4275-4D49-82FB-5CD113EEC651 Q43018917-4D78F8FC-AB64-4C37-8879-2426C74B5FAD Q44583870-6BC713E0-1ECE-4705-8C51-2778579FC299 Q47141798-B2CC1936-EC95-4ABA-AFA6-6A68011F2F13 Q47191829-5DCD4335-EFD3-4587-A44B-C5CB2FDA2263 Q47416057-530BA6F1-F075-4849-8604-DF30EBADC1F4 Q48293355-A11282D0-0DC9-4E99-A6CB-60B8E4D253E4

P2860

Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma.

http://www.wikidata.org/entity/Q40345265

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Different residues mediate rec ...... ator-activated receptor gamma.

@en

type

label

Different residues mediate rec ...... ator-activated receptor gamma.

@en

prefLabel

Different residues mediate rec ...... ator-activated receptor gamma.

@en

P1433

Q40345265-08C06C6B-6CD5-4DE3-9F79-33A468891BE2

P1476

Q40345265-2526B480-03C2-4027-9020-42B4850A2319

P2093

Q40345265-0A4DB9FB-CB30-48E9-9924-9C460E88FC8B

Q40345265-14C058DD-13E1-42C3-8B6C-5CA0E709C7EB

Q40345265-281160F4-9B64-4243-ACAC-1D522E1229CD

Q40345265-28188107-5B42-4A87-B67F-4FA7B1F65783

Q40345265-2F510C9C-30C9-423B-826C-9433E792B929

Q40345265-324E9C42-A9FB-41EB-9E77-00A02727CEC2

Q40345265-426B508E-9FF9-4D0E-BE27-1E125A0F3BB5

Q40345265-5017D495-3E39-4DAC-A89A-AE160E9AF3A9

Q40345265-6D6698BB-B7E5-4BFA-85FE-15841C1DB2D5

Q40345265-A3E909CB-E556-4705-A8AC-BEBBDBA4CD5B

P304

Q40345265-BAC89398-93BC-47FE-BB9F-C8857DCB21F6

P31

Q40345265-94BA4F70-FCFA-4813-B02B-8E89598331F6

P356

Q40345265-2A4BF743-6A3D-4899-B228-BC50B6028443

P407

Q40345265-72C01466-3030-4433-A1FD-C778063F69EA

P433

Q40345265-FAF4C2C0-5F7C-406D-A586-5D6262D6A856

P478

Q40345265-DF05A570-5A33-4B84-99C1-839E8DE402E2

P50

Q40345265-65AC2EDE-5BD1-41A9-84F4-4DBD7C315851

P577

Q40345265-BFD88825-6B4A-4534-8951-A01D5DFA1068

P698

Q40345265-E1D2C041-1022-400F-86FB-CA37F034E3A0

P921

Q40345265-4195BBE7-515A-4BB9-B79C-DC5DFC74A304

P356

P1433

Journal of Biological Chemistry

P1476

Different residues mediate rec ...... rator-activated receptor gamma

@en

P2093

Abby Parrill

http://www.w3.org/2001/XMLSchema#string

Daniel L Baker

http://www.w3.org/2001/XMLSchema#string

Gabor Tigyi

http://www.w3.org/2001/XMLSchema#string

Hongbin Yuan

http://www.w3.org/2001/XMLSchema#string

Natalia Makarova

http://www.w3.org/2001/XMLSchema#string

Patrick Allison

http://www.w3.org/2001/XMLSchema#string

Robert Bittman

http://www.w3.org/2001/XMLSchema#string

Ryoko Tsukahara

http://www.w3.org/2001/XMLSchema#string

Tamotsu Tsukahara

http://www.w3.org/2001/XMLSchema#string

William J Valentine

http://www.w3.org/2001/XMLSchema#string

P304

3398-3407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M510843200

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

281

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16321982

http://www.w3.org/2001/XMLSchema#string

P921